Business Wire·Sep 30, 2026, 4:05 PM ET

Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech

Inogen signed a definitive agreement to divest its U.S. oxygen rental business to Rotech Healthcare for up to $25 million in cash consideration.
The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.
Inogen also entered a long-term supply agreement with Rotech to expand distribution of its oxygen concentrators through Rotech's network.
Following the deal, Inogen will adopt a streamlined business model to drive higher revenue growth & adjusted operating income while focusing on core respiratory innovation.
Inogen expects to classify the Rental Business as discontinued operations starting with its third-quarter 2026 financial results.
The Rental Business generated $24.3 million in revenue in the first half of 2026, reflecting a 9.8% year-over-year decline.
Inogen's Board approved a $15 million increase to its share repurchase authorization, bringing the total to $45 million upon closing of the transaction.
The expanded share repurchase program expires on June 30, 2028, or earlier if the maximum authorized amount is utilized.
Patients will retain access to Inogen products through existing distributors & the company's direct-to-consumer cash-pay sales channel.